APH vs STRO
Amphenol Corporation (APH) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the APH and STRO stock pages for the full models.
Not investment advice.